<main class="news-article" role="main" lang="en">
      
<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
    <span class="govuk-caption-xl gem-c-title__context">
      News story
    </span>
  <h1 class="gem-c-title__text gem-c-title__text--long">
    Commercial cannabidiol (CBD) products: call for evidence
  </h1>
</div>
  </div>
  
  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Advisory Council on the Misuse of Drugs (ACMD) call for evidence on cannabinoids in CBD products.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div data-module="gem-toggle" class="gem-c-metadata">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a href="/government/organisations/advisory-council-on-the-misuse-of-drugs" class="govuk-link">Advisory Council on the Misuse of Drugs</a>

      </dd>
      <dt class="gem-c-metadata__term">Published:</dt>
      <dd class="gem-c-metadata__definition">26 March 2021</dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>




<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds content-bottom-margin">
    <div class="responsive-bottom-margin">
      <figure class="app-c-figure" lang="en">
    <img alt="Close-up of person writing in notebook." class="app-c-figure__image" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/117996/s300_s960_note_taking.png">
  <figcaption class="app-c-figure__figcaption">
  </figcaption>
</figure>

      
<div class="gem-c-govspeak govuk-govspeak direction-ltr" data-module="govspeak">
    
        <div class="govspeak">
<p>The Advisory Council on the Misuse of Drugs (ACMD) has been <a class="govuk-link" href="https://www.gov.uk/government/publications/advice-on-consumer-cbd-cannabidiol-products">commissioned</a> to provide impartial and independent scientific advice on the acceptable levels of constituent cannabinoids in cannabidiol (CBD) products (in other words, other than CBD itself) marketed as consumer products.</p>

<p>The commission does not extend to prescribed products/medicines. The ACMD invites all sections of society to provide written evidence with regards to this <a href="https://www.gov.uk/government/publications/advice-on-consumer-cbd-cannabidiol-products" class="govuk-link">commission</a>.</p>

<p>We are specifically seeking evidence on the following questions. Your written submission can provide responses to some or all of the questions:</p>

<ol>
  <li>The commission refers to the cannabinoids Δ9-THC, CBN and THCV. Are there any further phytocannabinoids which should be considered? If so, which cannabinoids and please provide evidence.</li>
  <li>At what dose would each of these cannabinoids cause a psychoactive effect in humans? Are there any potential harmful effects at these doses?</li>
  <li>What are the conditions that precursors of cannabinoids such as Δ9-THCA-A might be transformed into controlled cannabinoids?</li>
  <li>What is the combined level of the psychoactive cannabinoids that would not produce a psychoactive effect (in other words maximum combined dose of active ingredients) given the standard use of consumer CBD products?</li>
  <li>Are you aware of any evidence of CBD products causing adverse reactions or harms which might be attributable to cannabinoid impurities? If so, please attach such evidence.</li>
  <li>For producers of CBD-containing products for supply to consumers, what certification of quality of CBD extracts from raw materials do you require or expect?</li>
  <li>For which controlled phytocannabinoids are there reference standards available or likely to become available in the near future for their use in testing?</li>
</ol>

<p>Please note that owing to the specific focus of this ministerial commission, the ACMD will only consider information relevant to these questions. Additional information will not be considered.</p>

<p>If you would like to submit written evidence, please email the ACMD Secretariat at <a href="mailto:acmd@homeoffice.gov.uk" class="govuk-link">acmd@homeoffice.gov.uk</a> by Wednesday 21 April.</p>
</div>

</div>
    </div>

    <div class="dont-print responsive-bottom-margin">
        <div class="gem-c-share-links " data-module="gem-track-click">
      <h2 class="gem-c-share-links__title">Share this page</h2>

    <ul class="gem-c-share-links__list">
        <li class="gem-c-share-links__list-item">
          <a data-track-action="facebook" rel="noopener noreferrer external" data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;facebook&quot;,&quot;socialTarget&quot;:&quot;https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fcommercial-cannabidiol-cbd-products-call-for-evidence&quot;}" class="gem-c-share-links__link " href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fcommercial-cannabidiol-cbd-products-call-for-evidence" data-track-category="social media" target="_blank">
            <span class="gem-c-share-links__link-icon">
                <svg width="32" xmlns="http://www.w3.org/2000/svg" height="32">
                  <path fill="currentColor" d="M31.006 0H.993A.997.997 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.013a.998.998 0 0 0 .994-.993V.993A.999.999 0 0 0 31.006 0z"></path>
                  <path fill="#FFF" d="M17.892 10.751h1.787V8.009L17.216 8c-2.73 0-3.352 2.045-3.352 3.353v1.828h-1.581v2.824h1.581V24h3.322v-7.995h2.242l.291-2.824h-2.533V11.52c.001-.623.415-.769.706-.769z"></path>
                </svg>

            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Facebook
</a>
        </li>
        <li class="gem-c-share-links__list-item">
          <a data-track-options="{&quot;socialAction&quot;:&quot;share&quot;,&quot;socialNetwork&quot;:&quot;twitter&quot;,&quot;socialTarget&quot;:&quot;https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fcommercial-cannabidiol-cbd-products-call-for-evidence\u0026text=Commercial%20cannabidiol%20%28CBD%29%20products%3A%20call%20for%20evidence&quot;}" href="https://twitter.com/share?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fnews%2Fcommercial-cannabidiol-cbd-products-call-for-evidence&amp;text=Commercial%20cannabidiol%20%28CBD%29%20products%3A%20call%20for%20evidence" data-track-action="twitter" class="gem-c-share-links__link " target="_blank" rel="noopener noreferrer external" data-track-category="social media">
            <span class="gem-c-share-links__link-icon">
                <svg xmlns="http://www.w3.org/2000/svg" height="32" width="32">
                  <path d="M31.007 0H.993A.999.999 0 0 0 0 .993v30.014c0 .55.452.993.993.993h30.014a.997.997 0 0 0 .993-.993V.993A.998.998 0 0 0 31.007 0z" fill="currentColor"></path>
                  <path fill="#FFF" d="M8 21.027a9.286 9.286 0 0 0 5.032 1.475c6.038 0 9.34-5.002 9.34-9.339 0-.143-.004-.284-.012-.425a6.619 6.619 0 0 0 1.639-1.699c-.6.265-1.234.439-1.885.516a3.287 3.287 0 0 0 1.443-1.816 6.571 6.571 0 0 1-2.086.797 3.28 3.28 0 0 0-5.592 2.993 9.311 9.311 0 0 1-6.766-3.43 3.294 3.294 0 0 0-.443 1.651 3.28 3.28 0 0 0 1.46 2.732 3.278 3.278 0 0 1-1.488-.411v.041a3.288 3.288 0 0 0 2.633 3.22 3.28 3.28 0 0 1-1.481.055 3.285 3.285 0 0 0 3.065 2.281 6.59 6.59 0 0 1-4.076 1.404A6.76 6.76 0 0 1 8 21.027z"></path>
                </svg>

            </span>          <span class="govuk-visually-hidden">
              Share on
          </span>
          Twitter
</a>
        </li>
    </ul>
</div>
    </div>

    <div class="app-c-published-dates " lang="en">
    Published 26 March 2021
</div>

  </div>

  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav class="gem-c-related-navigation__nav-section" data-module="gem-toggle" role="navigation">

    <h2 data-track-count="footerRelatedItemSection" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer">Explore the topic</h2>

  <ul data-module="gem-track-click" class="gem-c-related-navigation__link-list">


        <li class="gem-c-related-navigation__link"><a data-track-options="{&quot;dimension28&quot;:&quot;1&quot;,&quot;dimension29&quot;:&quot;Medicines, medical devices&quot;}" href="/health-and-social-care/medicines-medical-devices-blood" data-track-label="/health-and-social-care/medicines-medical-devices-blood" data-track-category="relatedLinkClicked" class="gem-c-related-navigation__section-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic">Medicines, medical devices</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>